178 related articles for article (PubMed ID: 18155709)
1. Improved resistance to serum oxidation in Gilbert's syndrome: a mechanism for cardiovascular protection.
Bulmer AC; Blanchfield JT; Toth I; Fassett RG; Coombes JS
Atherosclerosis; 2008 Aug; 199(2):390-6. PubMed ID: 18155709
[TBL] [Abstract][Full Text] [Related]
2. Protection from age-related increase in lipid biomarkers and inflammation contributes to cardiovascular protection in Gilbert's syndrome.
Wallner M; Marculescu R; Doberer D; Wolzt M; Wagner O; Vitek L; Bulmer AC; Wagner KH
Clin Sci (Lond); 2013 Sep; 125(5):257-64. PubMed ID: 23566065
[TBL] [Abstract][Full Text] [Related]
3. Bilirubin, platelet activation and heart disease: a missing link to cardiovascular protection in Gilbert's syndrome?
Kundur AR; Singh I; Bulmer AC
Atherosclerosis; 2015 Mar; 239(1):73-84. PubMed ID: 25576848
[TBL] [Abstract][Full Text] [Related]
4. Bilirubin and beyond: a review of lipid status in Gilbert's syndrome and its relevance to cardiovascular disease protection.
Bulmer AC; Verkade HJ; Wagner KH
Prog Lipid Res; 2013 Apr; 52(2):193-205. PubMed ID: 23201182
[TBL] [Abstract][Full Text] [Related]
5. Decreased oxidation susceptibility of plasma low density lipoproteins in patients with Gilbert's syndrome.
Yesilova Z; Serdar M; Ercin CN; Gunay A; Kilciler G; Hasimi A; Uygun A; Kurt I; Erbil MK; Dagalp K
J Gastroenterol Hepatol; 2008 Oct; 23(10):1556-60. PubMed ID: 18522683
[TBL] [Abstract][Full Text] [Related]
6. Decreased small dense LDL levels in Gilbert's syndrome.
Tapan S; Karadurmus N; Dogru T; Ercin CN; Tasci I; Bilgi C; Kurt I; Erbil MK
Clin Biochem; 2011 Mar; 44(4):300-3. PubMed ID: 21167147
[TBL] [Abstract][Full Text] [Related]
7. Mildly elevated unconjugated bilirubin is associated with reduced platelet activation-related thrombogenesis and inflammation in Gilbert's syndrome.
Kundur AR; Santhakumar AB; Bulmer AC; Singh I
Platelets; 2017 Dec; 28(8):779-785. PubMed ID: 28300459
[TBL] [Abstract][Full Text] [Related]
8. Haem catabolism: a novel modulator of inflammation in Gilbert's syndrome.
Wallner M; Bulmer AC; Mölzer C; Müllner E; Marculescu R; Doberer D; Wolzt M; Wagner OF; Wagner KH
Eur J Clin Invest; 2013 Sep; 43(9):912-9. PubMed ID: 23865893
[TBL] [Abstract][Full Text] [Related]
9. Hepatic uptake of organic anions affects the plasma bilirubin level in subjects with Gilbert's syndrome mutations in UGT1A1.
Persico M; Persico E; Bakker CT; Rigato I; Amoroso A; Torella R; Bosma PJ; Tiribelli C; Ostrow JD
Hepatology; 2001 Mar; 33(3):627-32. PubMed ID: 11230743
[TBL] [Abstract][Full Text] [Related]
10. Reduced circulating oxidized LDL is associated with hypocholesterolemia and enhanced thiol status in Gilbert syndrome.
Boon AC; Hawkins CL; Bisht K; Coombes JS; Bakrania B; Wagner KH; Bulmer AC
Free Radic Biol Med; 2012 May; 52(10):2120-7. PubMed ID: 22521902
[TBL] [Abstract][Full Text] [Related]
11. Bilirubin scavenges chloramines and inhibits myeloperoxidase-induced protein/lipid oxidation in physiologically relevant hyperbilirubinemic serum.
Boon AC; Hawkins CL; Coombes JS; Wagner KH; Bulmer AC
Free Radic Biol Med; 2015 Sep; 86():259-68. PubMed ID: 26057938
[TBL] [Abstract][Full Text] [Related]
12. Investigation of the aortic pulse wave velocity in patients with Gilbert's syndrome.
Arslan E; Çakar M; Şarlak H; Kılınç A; Demirbaş S; Ay SA; Karaman M; Bulucu F; Sağlam K
Clin Exp Hypertens; 2013; 35(7):512-5. PubMed ID: 23286369
[TBL] [Abstract][Full Text] [Related]
13. Abnormal hepatic transport of indocyanine green in Gilbert's syndrome.
Martin JF; Vierling JM; Wolkoff AW; Scharschmidt BF; Vergalla J; Waggoner JG; Berk PD
Gastroenterology; 1976 Mar; 70(3):385-91. PubMed ID: 814028
[TBL] [Abstract][Full Text] [Related]
14. Serum metabolomics analysis reveals increased lipid catabolism in mildly hyperbilirubinemic Gilbert's syndrome individuals.
Hana CA; Tran LV; Mölzer C; Müllner E; Hörmann-Wallner M; Franzke B; Tosevska A; Zöhrer PA; Doberer D; Marculescu R; Bulmer AC; Freisling H; Moazzami AA; Wagner KH
Metabolism; 2021 Dec; 125():154913. PubMed ID: 34653509
[TBL] [Abstract][Full Text] [Related]
15. [A NEW LOOK AT GILBERT SYNDROME (LITERATURE REVIEW)].
Gorbunova O; Chernysheva E
Georgian Med News; 2019 Nov; (296):75-81. PubMed ID: 31889709
[TBL] [Abstract][Full Text] [Related]
16. Serum free fatty acids and bilirubin concentration during fasting in patients with Gilbert's syndrome and normal controls.
Orzes N; Tamaro G; Parco S; Baldini G; Lunazzi GC; Sottocasa GL; Mangiarotti MA; Tiribelli C
Ric Clin Lab; 1987; 17(1):61-6. PubMed ID: 3589403
[TBL] [Abstract][Full Text] [Related]
17. The effects of Gilbert's syndrome on the mean platelet volume and other hematological parameters.
Cure MC; Cure E; Kirbas A; Cicek AC; Yuce S
Blood Coagul Fibrinolysis; 2013 Jul; 24(5):484-8. PubMed ID: 23348429
[TBL] [Abstract][Full Text] [Related]
18. Hyperbilirubinemia, augmentation of endothelial function, and decrease in oxidative stress in Gilbert syndrome.
Maruhashi T; Soga J; Fujimura N; Idei N; Mikami S; Iwamoto Y; Kajikawa M; Matsumoto T; Kihara Y; Chayama K; Noma K; Nakashima A; Tomiyama H; Takase B; Yamashina A; Higashi Y
Circulation; 2012 Jul; 126(5):598-603. PubMed ID: 22773454
[TBL] [Abstract][Full Text] [Related]
19. The utility of rifampin in diagnosing Gilbert's syndrome.
Murthy GD; Byron D; Shoemaker D; Visweswaraiah H; Pasquale D
Am J Gastroenterol; 2001 Apr; 96(4):1150-4. PubMed ID: 11316162
[TBL] [Abstract][Full Text] [Related]
20. Effects of unconjugated bilirubin on chromosomal damage in individuals with Gilbert's syndrome measured with the micronucleus cytome assay.
Wallner M; Blassnigg SM; Marisch K; Pappenheim MT; Müllner E; Mölzer C; Nersesyan A; Marculescu R; Doberer D; Knasmüller S; Bulmer AC; Wagner KH
Mutagenesis; 2012 Nov; 27(6):731-5. PubMed ID: 22874647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]